Who owns the MIRATI THERAPEUTICS trademark?

The MIRATI THERAPEUTICS trademark is owned by Mirati Therapeutics, Inc..

What class is the MIRATI THERAPEUTICS trademark registered in?

The MIRATI THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for MIRATI THERAPEUTICS?

The USPTO serial number for MIRATI THERAPEUTICS is 90739552.

What is the registration number for MIRATI THERAPEUTICS?

MIRATI THERAPEUTICS is registered under USPTO registration number 7019943.

MIR

USPTO Trademark Record

REGISTERED

MIRATI THERAPEUTICS

SN 90739552·Reg 7019943·Filed May 27, 2021

Owner Mirati Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

MIRATI THERAPEUTICS (Serial No. 90739552), Registration No. 7019943, is a registered US trademark filed on May 27, 2021 by Mirati Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: April 04, 2029

Mark Intelligence

MIRATI THERAPEUTICS (Reg. #7019943) is a registered US trademark that has been protecting its owner, Mirati Therapeutics, Inc., since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 27, 2021

SERIAL

90739552

REG#

7019943

REGISTERED

Apr 04, 2023

Owner

Applicant

Mirati Therapeutics, Inc.

Entity

Corporation

State

Address

3545 Cray Court, San Diego, CA, 92121

Country

Attorney

NameMarilyn F. Kelly

Law firm

Marilyn F. Kelly Bristol-Myers Squibb Company

Docket

00163793-US

Address

P.O. Box 4000, Trademark Dept., Mailstop D.4243, Princeton, NJ 08648-4000, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMay 27, 2021

Serial Number90739552

Registration No.7019943

Registration DateApr 04, 2023

Status DateApr 04, 2023

Published for OppositionFeb 15, 2022

Mark TypeStylized characters

Attorney Docket00163793-US

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Dec 13, 2022

First use in commerce: Dec 13, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

30 events

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 25, 2024

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 25, 2024

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 25, 2024

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Apr 04, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 04, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 28, 2023

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 27, 2023

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Feb 01, 2023

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 30, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

USE AMENDMENT FILED

Jan 02, 2023

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Jan 02, 2023

TEAS STATEMENT OF USE RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 13, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Oct 11, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Oct 11, 2022

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Oct 11, 2022

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 12, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Feb 15, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 15, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 26, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 10, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Jan 10, 2022

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 20, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 20, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 20, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Nov 08, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 08, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 08, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Nov 01, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 23, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 31, 2021

NEW APPLICATION ENTERED

MIRATI THERAPEUTICS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Mirati Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Marilyn F. Kelly

Resources

Company